Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
Provided By PR Newswire
Last update: Nov 25, 2025
SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it will participate at the Piper Sandler 37th Annual Healthcare Conference. The conference will take place December 2-4, 2025, in New York, New York.
Read more at prnewswire.com
